Yüklüyor......
Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis
The novel coronavirus SARS-CoV-2 disease “COVID-19” emerged in China and rapidly spread to other countries; due to its rapid worldwide spread, the WHO has declared this as a global emergency. As there is no specific treatment prescribed to treat COVID-19, the seeking of suitable therapeutics among e...
Kaydedildi:
| Yayımlandı: | Front Microbiol |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7390959/ https://ncbi.nlm.nih.gov/pubmed/32793181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2020.01796 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|